Last Updated 4 March 2023.
6 Vaccines Approved for Use in United States of America
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
Approval Source: fda.gov
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
Approval Source: bbc.com
-
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
2 trials in 1 country
Approval Source: fda.gov
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
Approval Source: nytimes.com
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
4 trials in 1 country
Approval Source: fda.gov
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Approval Source: nytimes.com
52 Vaccines in Clinical Trials in United States of America
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
-
COVAXX
UB-612- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 2 countries
-
Sanofi/GSK
VidPrevtyn Beta- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 30 countries
3 trials in 2 countries
-
Sanofi/GSK
Recombinant Protein- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 7 countries
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
Radboud University
ABNCoV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 3 countries
-
Inovio
INO-4800- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
10 trials in 9 countries
-
Arcturus Therapeutics Inc
ARCT-154- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 3 countries
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
4 trials in 1 country
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 35 countries
3 trials in 5 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Pfizer/BioNTech
BNT162b2s01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 2 countries
-
Pfizer/BioNTech
BNT162b1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
-
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
2 trials in 1 country
-
Moderna
Spikevax Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
5 trials in 4 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
-
Moderna
mRNA-1273.617.2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 1 country
-
Moderna
mRNA-1273.213- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 1 country
-
Moderna
mRNA-1273.211- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
Mahidol University
NDV-HXP-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 3 countries
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
16 trials in 2 countries
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 93 countries
39 trials in 18 countries
-
Kentucky Bioprocessing
KBP-201- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Arcturus Therapeutics Inc
ARCT-165- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 2 countries
-
Arcturus Therapeutics Inc
LUNAR-COV19/ARCT-021- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
6 trials in 2 countries
-
Moderna
mRNA-1073- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Moderna
mRNA-1283- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Moderna
mRNA-1283.211- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
Pfizer/BioNTech
BNT162b2 (B.1.1.7 + B.1.617.2)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
Pfizer/BioNTech
BNT162b2 (B.1.1.7)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
Pfizer/BioNTech
BNT162b2 (B.1.617.2)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
Pfizer/BioNTech
BNT162b5 Bivalent (WT/OMI BA.2)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
ImmunityBio Inc
hAd5-Covid-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
7 trials in 2 countries
-
Vaxart
VXA-CoV2-1.1-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
Aivita Biomedical Inc
AV-COVID-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
City of Hope Medical Center
COH04S1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
US Army Medical Research and Development Command
SpFN COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Speransa Therapeutics
PRIME-2-CoV_Beta- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 2 countries
-
Providence Health & Services
CORVax12- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
GlaxoSmithKline
CoV2 SAM (LNP)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
GlaxoSmithKline
CV0501- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 3 countries
-
GlaxoSmithKline
CV2CoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
HDT Bio
HDT-301- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Moderna
mRNA-1230- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 3 countries
-
Moderna
mRNA-1273.351- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
CyanVac LLC
CVXGA1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
NIAID
ChAdV68-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
NIAID
SAM-LNP-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Vaxart
VXA-CoV2-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Meissa Vaccines Inc
MV-014-212- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
4 Vaccines with Trials in United States of America are No Longer Progressing
-
Sanofi Pasteur
MRT5500- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 1 country
-
Altimmune Inc
AdCOVID- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
Merck Sharp & Dohme Corp
V590- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Merck Sharp & Dohme Corp
V591- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
2 trials in 3 countries